Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930527 · ClinicalTrials.gov registry record · Phase 2
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
A Phase 2 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00930527 is a Phase 2 study that was terminated before completion, run by Columbia University. The registered enrollment target is 10 participants.
The verdict
NCT00930527, a Phase 2 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
There are no data regarding the use of supplements to alleviate the musculoskeletal pain and stiffness inducted by the use of aromatase inhibitors. This study is designated to test the safety and efficacy of omega 3 fatty acid supplementation to alleviate musculoskeletal pain in postmenopausal breast cancer patients.
Interventions
- DIETARY_SUPPLEMENT Omega-3 Fatty Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930527
The ClinicalTrials.gov registry entry for NCT00930527 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 Fatty Acid is the first listed.
NCT00930527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930527 about?
NCT00930527 is a clinical study titled "Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors". There are no data regarding the use of supplements to alleviate the musculoskeletal pain and stiffness inducted by the use of aromatase inhibitors. This study is designated to test the safety and efficacy of omega 3 fatty acid supplementation to alleviate musculoskeletal pain in postmenopausal breas...
What is the current status of trial NCT00930527?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2009-06. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00930527?
The interventions under investigation include: Omega-3 Fatty Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00930527?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.